These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37017060)

  • 1. Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity.
    Roca Suarez AA; Batbold E; Bartosch B; Dashdorj N; Testoni B; Zoulim F
    Liver Int; 2023 Aug; 43 Suppl 1():87-95. PubMed ID: 37017060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future treatments for hepatitis delta virus infection.
    Asselah T; Loureiro D; Tout I; Castelnau C; Boyer N; Marcellin P; Mansouri A
    Liver Int; 2020 Feb; 40 Suppl 1():54-60. PubMed ID: 32077603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future anti-HDV treatment strategies, including those aimed at HBV functional cure.
    Tan YC; Lee GH; Huang DQ; Lim SG
    Liver Int; 2023 Jun; 43(6):1157-1169. PubMed ID: 35946084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.
    Soriano V; Moreno-Torres V; Treviño A; Corral O; de Mendoza C
    Drug Des Devel Ther; 2023; 17():155-166. PubMed ID: 36712949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapies for hepatitis delta virus infection.
    Loureiro D; Castelnau C; Tout I; Boyer N; Narguet S; Menasria Benazzouz S; Louis Z; Pons-Kerjean N; Giuly N; Marcellin P; Mansouri A; Asselah T
    Liver Int; 2021 Jun; 41 Suppl 1():30-37. PubMed ID: 34155804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis delta virus: From infection to new therapeutic strategies.
    Niro GA; Ferro A; Cicerchia F; Brascugli I; Durazzo M
    World J Gastroenterol; 2021 Jun; 27(24):3530-3542. PubMed ID: 34239267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
    Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D virus: Improving virological knowledge to develop new treatments.
    Khalfi P; Kennedy PT; Majzoub K; Asselah T
    Antiviral Res; 2023 Jan; 209():105461. PubMed ID: 36396025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of in vivo hepatitis D virus infection.
    Goyal A; Murray JM
    J Theor Biol; 2016 Jun; 398():9-19. PubMed ID: 27012516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
    Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
    Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis delta and HIV infection.
    Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
    Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
    Zhang Z; Urban S
    J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
    Polaris Observatory Collaborators
    J Hepatol; 2024 Feb; 80(2):232-242. PubMed ID: 38030035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
    Colagrossi L; Salpini R; Scutari R; Carioti L; Battisti A; Piermatteo L; Bertoli A; Fabeni L; Minichini C; Trimoulet P; Fleury H; Nebuloso E; De Cristofaro M; Cappiello G; Spanò A; Malagnino V; Mari T; Barlattani A; Iapadre N; Lichtner M; Mastroianni C; Lenci I; Pasquazzi C; De Sanctis GM; Galeota Lanza A; Stanzione M; Stornaiuolo G; Marignani M; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Perno CF; Coppola N; Svicher V
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29987240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aiming for cure in HBV and HDV infection.
    Petersen J; Thompson AJ; Levrero M
    J Hepatol; 2016 Oct; 65(4):835-848. PubMed ID: 27270043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
    Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options.
    Asselah T
    Clin Liver Dis; 2023 Nov; 27(4):985-995. PubMed ID: 37778781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.